These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 24201044)
1. Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway. Jangra A; Datusalia AK; Khandwe S; Sharma SS Pharmacol Biochem Behav; 2013 Dec; 114-115():43-51. PubMed ID: 24201044 [TBL] [Abstract][Full Text] [Related]
2. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. Jangra A; Datusalia AK; Sharma SS Neurol Res; 2014 Jul; 36(7):619-26. PubMed ID: 24620961 [TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy. Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836 [TBL] [Abstract][Full Text] [Related]
4. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Negi G; Kumar A; Kaundal RK; Gulati A; Sharma SS Neuropharmacology; 2010 Mar; 58(3):585-92. PubMed ID: 20005237 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease. Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100 [TBL] [Abstract][Full Text] [Related]
7. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Negi G; Kumar A; Sharma SS Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402 [TBL] [Abstract][Full Text] [Related]
8. Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract. Singh A; Bodakhe SH Curr Eye Res; 2021 Jan; 46(1):52-63. PubMed ID: 32631099 [TBL] [Abstract][Full Text] [Related]
9. PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats. Li WJ; Zhou J; Li B; Wang H; Peng YB; Wang Z J Sex Med; 2011 Apr; 8(4):1072-82. PubMed ID: 21235725 [TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats. Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320 [TBL] [Abstract][Full Text] [Related]
11. Exposure to fluoride exacerbates the cognitive deficit of diabetic patients living in areas with endemic fluorosis, as well as of rats with type 2 diabetes induced by streptozotocin via a mechanism that may involve excessive activation of the poly(ADP ribose) polymerase-1/P53 pathway. Xiang J; Qi XL; Cao K; Ran LY; Zeng XX; Xiao X; Liao W; He WW; Hong W; He Y; Guan ZZ Sci Total Environ; 2024 Feb; 912():169512. PubMed ID: 38145685 [TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016 [TBL] [Abstract][Full Text] [Related]
13. [Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes]. Huzyk MM; Diakun KO; Ianits'ka LV; Kuchmerovs'ka TM Ukr Biokhim Zh (1999); 2013; 85(1):62-70. PubMed ID: 23534291 [TBL] [Abstract][Full Text] [Related]
14. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Szkudelski T Exp Biol Med (Maywood); 2012 May; 237(5):481-90. PubMed ID: 22619373 [TBL] [Abstract][Full Text] [Related]
15. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Manna P; Das J; Ghosh J; Sil PC Free Radic Biol Med; 2010 Jun; 48(11):1465-84. PubMed ID: 20188823 [TBL] [Abstract][Full Text] [Related]
16. Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADP-ribose) polymerase activity and Jun N-terminal kinase/activator protein-1 pathway inhibition. Uehara N; Miki K; Tsukamoto R; Matsuoka Y; Tsubura A Exp Eye Res; 2006 Mar; 82(3):488-95. PubMed ID: 16168987 [TBL] [Abstract][Full Text] [Related]
18. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706 [TBL] [Abstract][Full Text] [Related]
19. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. Negi G; Kumar A; Sharma SS J Pineal Res; 2011 Mar; 50(2):124-31. PubMed ID: 21062351 [TBL] [Abstract][Full Text] [Related]
20. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy. Zhao HS; Shi XY; Wei WB; Wang NL Chin Med J (Engl); 2013; 126(9):1693-9. PubMed ID: 23652053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]